1.
Study of Lopinavir/Ritonavir in Severe COVID-19 Patients with Comorbid Hypertension and Diabetes Mellitus. Indian Journal of Forensic Medicine & Toxicology [Internet]. 2022 Oct. 10 [cited 2026 May 1];16(4):174-81. Available from: https://mail.medicopublication.com/index.php/ijfmt/article/view/18570